A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma

OBJECTIVE: Dysregulation of cell cycle progression (CCP) is one of the hallmarks of cancer. Here, our study is aimed at developing a CCP-derived gene signature for predicting high-risk population of hepatocellular carcinoma (HCC). METHODS: Our study retrospectively analyzed the transcriptome profili...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Yongfeng, Leng, Junzhi, Jin, Dong, Liu, Di, Wang, Genwang, Wang, Qi, Wang, Yanyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553501/
https://www.ncbi.nlm.nih.gov/pubmed/34721731
http://dx.doi.org/10.1155/2021/1986159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553501/
https://www.ncbi.nlm.nih.gov/pubmed/34721731
http://dx.doi.org/10.1155/2021/1986159

Ejemplares similares